Chronic inflammation after severe traumatic brain injury: Characterization and associations with outcome at 6 and 12 months postinjury

Journal of Head Trauma Rehabilitation

Volumn 30, Issue 6, 2015, Pages 369-381

  Kumar, Raj G ^a   Boles, Jennifer A ^a   Wagner, Amy K ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CalvertHealth   (United States)

Author keywords

Cytokines; Inflammation; Interleukins; Rehabilomics; Traumatic brain injury

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN DERIVATIVE;

ADULT; ARTICLE; CHRONIC INFLAMMATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HUMAN; IMMUNOASSAY; INJURY SEVERITY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION AND POPULATION RELATED PHENOMENA; PROSPECTIVE STUDY; TRAUMATIC BRAIN INJURY; VISUAL SYSTEM; BLOOD; BRAIN INJURIES; CASE CONTROL STUDY; CHRONIC DISEASE; COMPLICATION; CONFIDENCE INTERVAL; DISEASE COURSE; INFLAMMATION; INJURY SCALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PENNSYLVANIA; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; BIOMARKERS; BRAIN INJURIES; CASE-CONTROL STUDIES; CHRONIC DISEASE; CONFIDENCE INTERVALS; CYTOKINES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLASGOW COMA SCALE; HUMANS; INFLAMMATION; INJURY SEVERITY SCORE; INTERLEUKINS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PENNSYLVANIA; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TRAUMA CENTERS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947036082     PISSN: 08859701     EISSN: 1550509X     Source Type: Journal    
DOI: 10.1097/HTR.0000000000000067     Document Type: Article

References (79)

1. Faul M, Xu L, Wald M, Coronado V. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths.Centers forDiseaseControl and Prevention, National Center for Injury Prevention and Control; 2010.
2. Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993;34(2):216-222.
3. Schmidt OI, Heyde CE, Ertel W, Stahel PF. Closed head injury-an inflammatory disease? Brain Res Brain Res Rev. 2005;48(2):388-399. doi:10.1016/j.brainresrev.2004.12.028.
4. Wagner AK, Brett CA, McCullough EH, et al. Persistent hypogonadism influences estradiol synthesis, cognition and outcome in males after severe TBI. Brain Inj. 2012;26(10):1226-1242.
5. Rink A, Fung KM, Trojanowski JQ, Lee VM, Neugebauer E, McIntosh TK. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol. 1995;147(6):1575-1583.
6. Wagner AK, McCullough EH, Niyonkuru C, et al. Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J Neurotrauma. 2011;28(6):871-888.
7. Feuerstein GZ, Wang X, Barone FC. The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation. 1998;5(3-4):143-159.
8. Ghirnikar RS, Lee YL, Eng LF. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res. 1998;23(3):329-340.
9. Jeong H-K, Ji K, Min K, Joe E-H. Brain inflammation and microglia: facts and misconceptions. Exp Neurobiol. 2013;22(2):59-67.
10. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: a doubleedged sword. Curr Opin Crit Care. 2002;8(2):101-105.
11. Shlosberg D, Benifla M, Kaufer D, Friedman A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol. 2010;6(7):393-403. doi:10.1038/nrneurol.2010.74.
12. Buttram SDW, Wisniewski SR, Jackson EK, et al. Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. J Neurotrauma. 2007;24(11):1707-1717. doi:10.1089/neu.2007.0349.
13. Bell MJ, Kochanek PM, Doughty LA, et al. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J Neurotrauma. 1997;14(7):451-457.
14. Singhal A, Baker AJ, Hare GMT, Reinders FX, Schlichter LC, Moulton RJ. Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J Neurotrauma. 2002;19(8):929-937. doi:10.1089/089771502320317087.
15. Maier B, Schwerdtfeger K, Mautes A, et al. Differential release of interleukins 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock. 2001;15(6):421-426.
16. Hensler T, Sauerland S, Riess P, et al. The effect of additional brain injury on systemic interleukin (IL)-10 and IL-13 levels in trauma patients. Inflamm Res. 2000;49(10):524-528.
17. Shiozaki T, Hayakata T, Tasaki O, et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock. 2005;23(5):406-410.
18. Wang H-C, Wang P-M, Lin Y-J, et al. Serum adhesion molecules, outcome and neuro-psychological function in acute traumatic brain injury patients. Clin Chim Acta Int J ClinChem. 2013;423:122-129. doi:10.1016/j.cca.2013.04.023.
19. Lucas S-M, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol. 2006;147(suppl 1):S232-S240. doi:10.1038/sj.bjp.0706400.
20. Rothwell NJ. Annual review prize lecture cytokines-killers in the brain? J Physiol. 1999;514(pt 1):3-17.
21. Chiaretti A, Genovese O, Aloe L, et al. Interleukin 1 beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nerv Syst. 2005;21(3):185-193; discussion 194. doi:10.1007/s00381-004-1032-1.
22. Woodroofe MN, Sarna GS, Wadhwa M, et al. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol. 1991;33(3):227-236.
23. Maegele M, Sauerland S, Bouillon B, et al. Differential immunoresponses following experimental traumatic brain injury, bone fracture and "two-hit"-combined neurotrauma. Inflamm Res. 2007;56(8):318-323. doi:10.1007/s00011-007-6141-3.
24. Weckbach S, Perl M, Heiland T, et al. A new experimental polytrauma model in rats: molecular characterization of the early inflammatory response. Mediators Inflamm. 2012;2012:890816. doi:10.1155/2012/890816.
25. Woodcock T, Morganti-Kossmann MC. The role of markers of inflammation in traumatic brain injury. Front Neurol. 2013;4:18. doi:10.3389/fneur.2013.00018.
26. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007;24(suppl 1):S1-106. doi:10.1089/neu.2007.9999.
27. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81-84.
28. Baker SP, ONeill B, Haddon W Jr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14(3):187-196.
29. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1(7905):480-484.
30. SAS Institute Inc. SASR - 9.2 Language Reference: Concepts. 2nd ed. Cary, NC: SAS Institute Inc.; 2010.
31. Andaluz-Ojeda D, Bobillo F, Iglesias V, et al. A combined score of pro-and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine. 2012;57(3):332-336. doi:10.1016/j.cyto.2011.12.002.
32. Correia LCL, Andrade BB, Borges VM, et al. Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes. Clin Chim Acta. 2010;411(7-8):540-545. doi:10.1016/j.cca.2010.01.011.
33. Wakelkamp IMMJ, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves ophthalmopathy patients. Clin Endocrinol (Oxf). 2003;58(3):280-287. doi:10.1046/j.1365-2265.2003.01708.x.
34. Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM. Soluble cytokine receptors and the low 3, 5, 3-triiodothyronine syndrome in patients with nonthyroidal disease. J Clin Endocrinol Metab. 1995;80(3):971-976. doi:10.1210/jcem.80.3.7883859.
35. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845.
36. Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune response by head injury. Injury. 2007;38(12):1392-1400. doi:10.1016/j.injury.2007.10.005.
37. Zou H, Brayer SW, Hurwitz M, Niyonkuru C, Fowler LE, Wagner AK. Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury. Neurorehabil Neural Repair. 2013;27(9):878-888. doi:10.1177/1545968313491007.
38. Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain J Neurol. 2013;136(pt 1):28-42. doi:10.1093/brain/aws322.
39. Ramlackhansingh AF, Brooks DJ, Greenwood RJ, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 2011;70(3):374-383. doi:10.1002/ana.22455.
40. Toyama H, Hatano K, Suzuki H, et al. In vivo imaging of microglial activation using a peripheral benzodiazepine receptor ligand: [11C]PK-11195 and animal PET following ethanol injury in rat striatum. Ann Nucl Med. 2008;22(5):417-424. doi:10.1007/s12149-008-0136-1.
41. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314-1318. doi:10.1126/science.1110647.
42. Maier SF. Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav Immun. 2003;17(2):69-85.
43. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitaryadrenal axis by cytokines: actions and mechanisms of action. Physiol Rev. 1999;79(1):1-71.
44. Sorrells SF, Sapolsky RM. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun. 2007;21(3): 259-272.
45. Deinzer R, Granrath N, Stuhl H, et al. Acute stress effects on local Il-1beta responses to pathogens in a human in vivo model. Brain Behav Immun. 2004;18(5):458-467. doi:10.1016/j.bbi.2003.11.008.
46. Oconnor KA, Johnson JD, HansenMK, et al. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res. 2003;991(1-2):123-132.
47. Santarsieri M, Niyonkuru C, McCullough EH, et al. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury. JNeurotrauma. 2014;31(8):699-712. doi:10.1089/neu.2013.3177.
48. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro-versus antiinflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181(1):176-180. doi:10.1086/315214.
49. Mellergard P, A neman O, Sjögren F, Säberg C, Hillman J. Differences in cerebral extracellular response of interleukin-1β, interleukin-6, and interleukin-10 after subarachnoid hemorrhage or severe head trauma in humans. Neurosurgery. 2011;68(1):12-19; discussion 19. doi:10.1227/NEU.0b013e3181ef2a40.
50. Oertelt-Prigione S. The influence of sex and gender on the immune response. Autoimmun Rev. 2012;11(6-7):A479-A485. doi:10.1016/j.autrev.2011.11.022.
51. Bird MD, Karavitis J, Kovacs EJ. Sex differences and estrogen modulation of the cellular immune response after injury. Cell Immunol. 2008;252(1-2):57-67. doi:10.1016/j.cellimm.2007.09.007.
52. Pankow JS, Folsom AR, Cushman M, et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis. 2001;154(3):681-689. doi:10.1016/S0021-9150(00)00586-4.
53. Dupuis J, Larson MG, Vasan RS, et al. Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis. 2005;182(2):307-314. doi:10.1016/j .atherosclerosis.2005.02.015.
54. Schnabel RB, Lunetta KL, Larson MG, et al. The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations. Circ Cardiovasc Genet. 2009;2(3):229-237. doi:10.1161/CIRCGENETICS.108.804245.
55. Schnabel R, Larson MG, Dupuis J, et al. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension. 2008;51(6):1651-1657. doi:10.1161/HYPERTENSIONAHA.107.105668.
56. Curran JE, Jowett JBM, Elliott KS, et al. Genetic variation in selenoprotein S influences inflammatory response. Nat Genet. 2005;37(11):1234-1241. doi:10.1038/ng1655.
57. Waters RJ, Murray GD, Teasdale GM, et al. Cytokine gene polymorphisms and outcome after traumatic brain injury. J Neurotrauma. 2013;30(20):1710-1716. doi:10.1089/neu.2012.2792.
58. Diamond M, Ritter A, Failla M, et al. IL-1β influences on posttraumatic epilepsy development: a genetics and proteomics cohort study. Epilepsia Press. 2014.
59. Farrer LA, Cupples L, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997;278(16):1349-1356. doi:10.1001/jama.1997.03550160069041.
60. Vitek MP, Brown CM, Colton CA. APOE genotypespecific differences in the innate immune response. Neurobiol Aging. 2009;30(9):1350-1360. doi:10.1016/j .neurobiolaging.2007.11.014.
61. Klimas NG, Broderick G, Fletcher MA. Biomarkers for chronic fatigue. Brain Behav Immun. 2012;26(8):1202-1210. doi:10.1016/j.bbi.2012.06.006.
62. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7(1):31-40. doi:10.1038/nrneurol.2010.178.
63. Mayer CL, Huber BR, Peskind E. Traumatic brain injury, neuroinflammation, and posttraumatic headaches. Headache. 2013;53(9):1523-1530. doi:10.1111/head.12173.
64. Kemper RH, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia Int J Headache. 2001;21(5):549-557.
65. Patel A. Review: the role of inflammation in depression. Psychiatr Danub. 2013;25(suppl 2):S216-S223.
66. Vogelzangs N, Beekman ATF, de Jonge P, Penninx BWJH. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry. 2013;3:e249. doi:10.1038/tp.2013.27.
67. Serafini G, Pompili M, Elena Seretti M, et al. The role of inflammatory cytokines in suicidal behavior: a systematic review. Eur Neuropsychopharmacol. 2013;23(12):1672-1686. doi:10.1016/j.euroneuro.2013.06.002.
68. Rao V, Lyketsos C. Neuropsychiatric sequelae of traumatic brain injury. Psychosomatics. 2000;41(2):95-103. doi:10.1176/appi.psy.41.2.95.
69. Cantor JB, Ashman T, Gordon W, et al. Fatigue after traumatic brain injury and its impact on participation and quality of life. J Head Trauma Rehabil. 2008;23(1):41-51. doi:10.1097/01.HTR.0000308720.70288.af.
70. Theeler B, Lucas S, Riechers RG II, Ruff RL. Posttraumatic headaches in civilians and military personnel: a comparative, clinical review. Headache. 2013;53(6):881-900. doi:10.1111/head.12123.
71. Browne KD, Iwata A, Putt ME, Smith DH. Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats. Exp Neurol. 2006;201(2):301-307. doi:10.1016/j.expneurol.2006.04.008.
72. Homsi S, Piaggio T, Croci N, et al. Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve week follow-up study. J Neurotrauma. 2010;27(5):911-921. doi:10.1089/neu.2009.1223.
73. Bye N, Habgood MD, Callaway JK, et al. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol. 2007;204(1):220-233. doi:10.1016/j.expneurol.2006.10. 013.
74. Thomale UW, Bender M, Casalis P, et al. Tacrolimus depresses local immune cell infiltration but fails to reduce cortical contusion volume in brain-injured rats. Immunobiology. 2007;212(7): 567-576.
75. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104(6):1832-1847.
76. Suleyman H, Demircan B, Karagoz Y. Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol Rep. 2007;59(3):247-258.
77. Maiden L, Thjodleifsson B, Seigal A, et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol. 2007;5(9):1040-1045. doi:10.1016/j.cgh.2007.04.031.
78. Ong CKS, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007;5(1):19-34. doi:10.3121/cmr.2007.698.
79. Ziebell JM, Morganti-Kossmann MC. Involvement of pro-and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurother J Am Soc Exp Neurother. 2010;7(1):22-30. doi:10.1016/j.nurt.2009.10.016.